Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 21
Healthy Volunteers: f
View:

• Provision of signed and dated informed consent form

• Male or female

• Age: birth to 21 years of age

• Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization.

Locations
United States
Washington, D.c.
Children's National Hospital
RECRUITING
Washington D.c.
Contact Information
Primary
Damon Judges
d.judges@compremium.ch
+41775071995
Time Frame
Start Date: 2025-03-10
Estimated Completion Date: 2026-03-31
Participants
Target number of participants: 100
Treatments
Experimental: CPMX2 measurement arm
CPMX2 measurements will be compared against invasive CVP measurements
Related Therapeutic Areas
Sponsors
Leads: Compremium AG

This content was sourced from clinicaltrials.gov